CClinicalTrials.gg
Active, not recruitingNCT04017273Updated Feb 23, 2024

Older Emergency Department Users and Hospitalization After an Index Visit: Results of ER2 Database

An observational study in Chronic Conditions, Multiple and Medical Emergencies, sponsored by Jewish General Hospital. Active, not recruiting at 1 site in Canada. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2024-02-23.

Sponsored by Jewish General Hospital · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
10,971
Ages
75 Years and older
Sex
All
01

Study summary

This study evaluates the recommendations of a screening tool called: ER2 (Emergency Room Evaluation and Recommendations Form).This stool is used in Emergency Department by nurses, and it supposes to measure patient risk score.

Read the detailed description

Crowding and delay became chronic conditions in emergency departments (EDs) in high income countries. Emergency medicine has the mandate to provide care to any patient requesting treatment 24 hours a day. As there is a lack of primary care physicians who are able to provide the necessary care to patients, they are forced to seek care in ED. Among these ED users, more and more patients are aged over 65 and account for up to a quarter of all ED users. Older ED users comparted to their younger counterparts are more at risk for long length of stay in ED and hospital, and hospital admission during an index ED visit. The occurrence of these short-terms adverse events may be reduced if older ED users risk is assessed upon their ED arrival. Few studies have examined risk for short-terms adverse events. They suggested that clinical tools based on a brief geriatric assessment with timely appropriate interventions could reduce the occurrence of short-terms ED adverse events.

02

Conditions studied

  • Chronic Conditions, Multiple
  • Medical Emergencies
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's planned enrollment of 10,971 is above the median of 353 across 714 observational studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

Jewish General Hospital is the lead sponsor of 95 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
75 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

In this study will be enrolled people who are 75 years and over, and who come at Emergency not only for medical reason but also for social.

Inclusion criteria

  • Being 75 years and over
  • Brought at Emergency on medical stretcher

Exclusion criteria

Exclusion Criteria:

  • Being less than 75 years old
  • Never come at Emergency
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
10,971 participants (estimated)
Patient registry
No

Groups and cohorts

  • Observational

    The participants of this study will be seen at Emergency Department, and a nurse will perform a test called ER2 ( Emergency Room Evaluation and Recommendation).

06

What researchers measure

Primary outcomes

  1. Long length of hospital stay

    Long length of hospital stay represents an indicator of efficiency, and it refers to the average number of day that a patient spends in hospital.

    Time frame: Around 10 months

07

Study locations

1 site
  • Jewish General Hospital
    Montréal, Quebec H3T 1E2, Canada
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04017273
Lead sponsor
Jewish General Hospital
Responsible party
Olivier Beauchet (MD, Professor of Geriatrics, Jewish General Hospital) — Principal investigator
First posted
Jul 12, 2019
Start date
Jul 23, 2019
Primary completion
May 1, 2022
Completion
Dec 1, 2025 (estimated)
Last update
Feb 23, 2024

Study contacts

Olivier Beauchet, MD
principal investigator · Jewish General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion